Schedule 13D ownership disclosure

ImmunityBio Inc

Security class unavailable · CUSIP: 45256X103

Event date: 2022-08-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
65.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-299573
Form type
SC 13D/A
Filer
Cambridge Equities, LP
CIK
CIK 1629222
Filed
Dec 07, 2022
Reporting period
Aug 31, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub